Home › Type 1 Diabetes
Pag-aaral pangklinika para sa Type 1 Diabetes na nagre-recruit sa U.S.
139 pag-aaral para sa Type 1 Diabetes ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Aurora, CO26 pag-aaral
- Boston, MA21 pag-aaral
- Seattle, WA19 pag-aaral
- San Francisco, CA16 pag-aaral
- Chicago, IL16 pag-aaral
- New Haven, CT16 pag-aaral
- New York City, NY15 pag-aaral
- Indianapolis, IN14 pag-aaral
- Miami, FL14 pag-aaral
- Atlanta, GA13 pag-aaral
- Gainesville, FL13 pag-aaral
- Philadelphia, PA11 pag-aaral
- Durham, NC11 pag-aaral
- Minneapolis, MN10 pag-aaral
- San Diego, CA9 pag-aaral
- Charlottesville, VA9 pag-aaral
- Houston, TX9 pag-aaral
- Nashville, TN8 pag-aaral
- Cleveland, OH7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Dallas, TX7 pag-aaral
- Columbus, OH7 pag-aaral
- Orlando, FL7 pag-aaral
- Tampa, FL6 pag-aaral
- Baltimore, MD6 pag-aaral
- Kansas City, MO6 pag-aaral
- Buffalo, NY6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- Detroit, MI6 pag-aaral
- Mountain View, CA5 pag-aaral
- Louisville, KY5 pag-aaral
- Austin, TX5 pag-aaral
- Jacksonville, FL5 pag-aaral
- Concord, CA4 pag-aaral
- Memphis, TN4 pag-aaral
- Baldwin Park, CA4 pag-aaral
- Cincinnati, OH4 pag-aaral
- Rochester, MN4 pag-aaral
- Washington, DC3 pag-aaral
- Escondido, CA3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California38 pag-aaral
- Colorado27 pag-aaral
- Connecticut17 pag-aaral
- District of Columbia3 pag-aaral
- Florida32 pag-aaral
- Georgia15 pag-aaral
- Idaho3 pag-aaral
- Illinois16 pag-aaral
- Indiana14 pag-aaral
- Kentucky7 pag-aaral
- Maryland6 pag-aaral
- Massachusetts21 pag-aaral
- Michigan9 pag-aaral
- Minnesota13 pag-aaral
- Missouri9 pag-aaral
- New York23 pag-aaral
- North Carolina13 pag-aaral
- Ohio14 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania13 pag-aaral
- Tennessee11 pag-aaral
- Texas18 pag-aaral
- Utah5 pag-aaral
- Virginia11 pag-aaral
- Washington21 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Nagre-recruit
Edad 2 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07864168A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Nagre-recruitPhase 3
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06783309Food Insecurity Reduction & Strategy Team
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06329375Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?
Nagre-recruit
Edad 16 hanggang 20 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07793097Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07616206To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07287943Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Nob 9, 2026 · NCT07293715Long-Term Outcomes of Teplizumab in Routine Clinical Care
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07360080C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07807280A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Nagre-recruitPhase 3
Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Nagre-recruitPhase 3
Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07222332Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
Nagre-recruit
Edad 10 hanggang 20 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07720388Closed Loop and Education for Hypoglycemia Awareness Restoration
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06325202Starting Technology in At Risk Type 1 Diabetes Study
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06453928Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Nagre-recruitPhase 4
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05641753T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Nagre-recruit
Edad 18 hanggang 40 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07059806Sleep Coach for Adolescents With Type 1 Diabetes
Nagre-recruit
Edad 11 hanggang 17 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06516614Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Nagre-recruit
Edad 15 hanggang 24 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07434544Denosumab for Type 1 Diabetes
Nagre-recruitPhase 1/2
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06524960A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06919354The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Nagre-recruitPhase 2
Edad 25 hanggang 70 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06976619A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Nagre-recruitPhase 1/2
Edad 9 hanggang 20 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07061574Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07676565Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
Nagre-recruitPhase 1/2
Edad 18 hanggang 68 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT03746769Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.